October 24, 2017
3 min read
Pathways to Improved Patient and Prescriber Experiences
See the results, lessons, and future for UBC's proprietary patient access technology suite.
UBC Insights
Insights from
UBC's Expert Voices
Featured Updates
Blog
November 19, 2025
6 min read
Registry feasibility assessments for post-authorization safety studies (PASS): Learnings and Challenges
UBC recently completed a multi-country feasibility assessment to identify disease registries capable of supporting a PASS for a novel therapy targeting a hereditary muscular disorder. The study evaluated registry data elements, quality, and governance to ensure fit-for-purpose real-world data (RWD) for generating reliable RWE.
Blog
November 18, 2025
9 min read
Making the most of real-time pharmacovigilance oversight: Applying operational data analytics across diverse use cases
Learn how companies are making the most of their oversight capabilities by leveraging real-time data to improve the health of their pharmacovigilance program.
Blog
November 13, 2025
20 min read
Putting a Seatbelt on AI: How Risk-Based Integration is Transforming Drug Safety
AI is revolutionizing drug safety, but without proper guardrails, it can introduce new risks. Learn how risk-based integration strategies are helping life sciences companies harness AI’s power while maintaining trust, transparency, and compliance.
Posts by Date
Blog
Blog
October 13, 2017
2 min read
UBC in the News: Thought Leaders You Should Know
Catch up on the latest articles featuring UBC from this fall.
Blog
September 20, 2017
4 min read
Utilizing Clinical Trial Nursing Services to Improve Retention & Facilitate Data Collection in a Rare Disease Trial: A Case Study
Read how this service helped enrolled patients complete study requirements without dropoff.
Blog
August 1, 2017
3 min read
PharmaVoice 100 Honors Dr. Annette Stemhagen
Learn more about this award for one of UBC's key leaders.
Blog
June 15, 2017
3 min read
Ten Reasons to Plan Early and Conduct Post-Marketing Research
Read about the solutions for continued surveillance of product safety and for demonstrating value and effectiveness based on real-world evidence.
Blog
March 1, 2015
4 min read
Apple’s ResearchKit: The Panacea for Patient Recruitment?
Learn more about this latest offering from Apple and what it could mean for clinical research.
Previous
